Please see our instructional videos below for guidance and information on Leukaemia.
Different drug combinations have different toxicity profiles, associated complications and efficacy. Requiring lengthy discussion between patients and their doctor and treatment at a centre experienced in their delivery and care of patients being treated with them.
Clinical trials are not for everyone. Discussion about suitability is an “individual thing” and requires consideration of many factors and discussion between the CLL patient and Doctor.
Much discussion is required between the patient and doctor when understanding where you are, as tests may be better at predicting for populations and there is much individual variation to consider.
In this video Professor Chris Pepper of The Cardiff CLL Research Group, Institute of Cancer & Genetics at Cardiff University tells us a little about himself and how he became involved in CLL research, the work of the CLL research team and the Cancer Research Genetics Building and provides us with an overview of the CLL research work of the Cardiff CLL Group.
Cardiff CLL Research Group make significant breakthrough into improving prognostic testing for patients diagnosed with CLL As a patient it is really encouraging to hear Prof Pepper's evident excitement and hope for CLL patients moving into the new world of improved testing and treatment of CLL.
